Effects of clopidogrel vs prasugel vs ticagrelor on endothelial function, inflammatory and oxidative stress parameters and platelet function in patients undergoing coronary artery stenting. A randomised, prospective study.
Phase of Trial: Phase IV
Latest Information Update: 20 Sep 2016
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease; Coronary artery restenosis; Embolism and thrombosis
- Focus Pharmacodynamics
- Acronyms EST
- 20 Sep 2016 Last checked against ClinicalTrials.gov record.
- 09 Mar 2016 Status changed from recruiting to discontinued as per European Clinical Trials Database record.
- 23 Feb 2016 Planned End Date changed from 1 Aug 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.